Abstract
Ischemia and reperfusion injuries can lead to major compromises in cardiac function. While the intent of many of the past cardioprotective therapies was to protect the myocardium from ischemic necrosis, it may be that reperfusion injury following ischemia may occur despite such preventative attempts. There are continued efforts to identify improvements in myocardial protective strategies (pre- and postconditioning), and their ultimate goals are to minimize the risk of cellular injuries to all types of patients undergoing cardiovascular therapies, treatments, or surgeries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Edmunds LH (ed) (1997) Cardiac surgery in the adult. McGraw-Hill, New York, pp 295–318
Yellon DM, Rahimtoola SH, Opie LH et al (eds) (1997) New ischemic syndromes: beyond angina and infarction. Lippincott-Raven Publishers, New York, pp 10–20, 106–114
Opie LH (ed) (1998) The heart: physiology, from cell to circulation. Lippincott-Raven, Philadelphia, pp 515–589
Shen YT, Vatner SF (1995) Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 76:479–488
Bolli R, Marban E (1999) Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79:609–634
Karmazyn M, Moffat MP (1993) Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res 27:915–924
Miller WP, McDonald KS, Moss RL (1996) Onset of reduced Ca2+ sensitivity of tension during stunning in porcine myocardium. J Mol Cell Cardiol 28:689–697
Kusuoka H, Koretsune Y, Chacko VP et al (1990) Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning? Circ Res 66:1268–1276
McDonough JL, Labugger R, Pickett W et al (2001) Cardiac troponin I is modified in the myocardium of bypass patients. Circulation 103:58–64
Opie LH, du Toit EF (1992) Postischemic stunning: the two-phase model for the role of calcium as pathogen. J Cardiovasc Pharmacol 20:S1–S4
Aguilera IM, Vaughan RS (2000) Calcium and the anaesthetist. Anaesthesia 55:779–790
Robertie PG, Butterworth JF, Royster RL et al (1991) Normal parathyroid hormone responses to hypocalcemia during cardiopulmonary bypass. Anesthesiology 75:43–48
Chair N, Otto CW, Link MS et al (2010) 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care science. Circulation 122:S729–S767
Heusch G (2013) The regional myocardial flow-function relationship: a framework for an understanding of acute ischemia, hibernation, stunning and coronary microembolization. Circ Res 112:1535–1537
Bolli R, Patel BS, Jeroudi MO et al (1988) Demonstration of free radical generation in “stunned” myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 82:476–485
Heusch G, Schulz R (2002) Myocardial hibernation. Ital Heart J 3:282–284
Boden WE, Brooks WW, Conrad CH et al (1995) Incomplete, delayed functional recovery late after reperfusion following acute myocardial infarction: “maimed myocardium.”. Am Heart J 130:922–932
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136
Nelson BT, Ding X, Boney-Montoya J et al (2013) Metabolic hormone FGF21 Is induced in ground squirrels during hibernation but its overexpression is not sufficient to cause torpor. PLoS One 8:e53574
Lawson CS, Coltart DJ, Hearse DJ (1993) “Dose”-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol 25:1391–1402
Schultz JE, Rose E, Yao Z et al (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268:H2157–H2161
Coles JA Jr, Sigg DC, Iaizzo PA (2003) Role of kappa-opioid receptor activation in pharmacological preconditioning in swine. Am J Physiol Heart Circ Physiol 284:2091–2099
Sigg DC, Coles JA Jr, Gallagher WJ et al (2001) Opioid cardioprotection: myocardial function and energy metabolism. Ann Thorac Surg 72:1576–1582
Yellon DM, Downey JM (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83:1113–1151
Gross GJ (2003) Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 35:709–718
Cohn PF, Fox KM (2003) Silent myocardial ischemia. Circulation 108:1263–1277
Leaf A, Kang JX, Xiao YF (2008) Fish oil fatty acids as cardiovascular drugs. Curr Vasc Pharmacol 6:1–12
Xiao YF, Sigg DC, Ujhelyi MR, Wilhelm JJ, Richardson ES, Iaizzo PA (2008) Pericardial delivery of Omega-3 fatty acid: a novel approach to reduce myocardial infarct sizes and arrhythmias. Am J Physiol Heart Circ Physiol 294:H2212–H2218
Pacher P, Nivorozhkin A, Szabo C (2006) Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58:87–114
Fliss H, Gattinger D (1996) Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79:949–956
Opie LH, Coetzee WA (1988) Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention. Cardiovasc Drugs Ther 2:623–636
Manning AS, Hearse DJ (1984) Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 16:497–518
Wehrens XH, Doevendans PA, Ophuis TJ et al (2000) A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty. Am Heart J 139:430–436
Maes A, Van de Werf F, Nuyts J et al (1995) Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. Circulation 92:2072–2078
Reffelmann T, Kloner R (2006) The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol 101:359–372
Forde RC, Fitzgerald DJ (1997) Reactive oxygen species and platelet activation in reperfusion injury. Circulation 95:787–789
Menasche P, Peynet J, Haeffner-Cavaillon N et al (1995) Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass. Circulation 92:II334–II340
Anderson RE, Li TQ, Hindmarsh T et al (1999) Increased extracellular brain water after coronary artery bypass grafting is avoided by off-pump surgery. J Cardiothorac Vasc Anesth 13:698–702
Karmazyn M (1998) The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury. Keio J Med 47:65–72
Inserte J, Garcia-Dorado D, Ruiz-Meana M et al (1997) The role of the Na+-H+ exchange occurring during hypoxia in the genesis of reoxygenation-induced myocardial oedema. J Mol Cell Cardiol 29:1167–1175
Garcia-Dorado D, Gonzalez MA, Barrabes JA et al (1997) Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na(+)-H(+) exchange. Cardiovasc Res 35:80–89
Klein HH, Bohle RM, Pich S et al (1997) Time delay of cell death by Na+/H+ exchange inhibition in regionally ischemic, reperfused porcine hearts. J Cardiovasc Pharmacol 30:235–240
Shipolini AR, Yokoyama H, Galinanes M et al (1997) Na+/H+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation 96:3617–3625
Yoshida H, Karmazyn M (2000) Na(+)/H(+) exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium. Am J Physiol Heart Circ Physiol 278:H300–H304
Myers ML, Farhangkhoee P, Karmazyn M (1998) Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Cardiovasc Res 40:290–296
Mathur S, Karmazyn M (1997) Interaction between anesthetics and the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) in ischemic and reperfused rat hearts. Anesthesiology 87:1460–1469
Hartmann M, Decking UK (1999) Blocking Na(+)-H(+) exchange by cariporide reduces Na(+)-overload in ischemia and is cardioprotective. J Mol Cell Cardiol 31:1985–1995
Theroux P, Chaitman BR, Danchin N et al (2000) Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation 102:3032–3038
Myers ML, Karmazyn M (1996) Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694. Ann Thorac Surg 61:1400–1406
Zeymer U, Suryapranata H, Monassier JP et al (2001) The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol 38:1644–1650
Bugge E, Yterhus K (1995) Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart-a protective additive to ischaemic preconditioning. Cardiovasc Res 29:269–274
Dhalla NS, Elmoselhi AB, Hata T et al (2000) Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47:446–456
Khaper N, Rigatto C, Seneviratne C et al (1997) Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol 29:3335–3344
Kalaycioglu S, Sinci V, Imren Y et al (1999) Metoprolol prevents ischemia-reperfusion injury by reducing lipid peroxidation. Jpn Circ J 63:718–721
Feuerstein GZ, Yue TL, Cheng HY et al (1993) Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. J Hypertens 11:S41–S48
Iyengar SR, Charrette EJ, Iyengar CK et al (1976) Myocardial glycogen in prevention of perioperative ischemic injury of the heart: a preliminary report. Can J Surg 19:246–251
Yellon DM, Baxter GF (1999) Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc Med 9:245–249
Saraste A, Pulkki K, Kallajoki M et al (1997) Apoptosis in human acute myocardial infarction. Circulation 95:320–323
Baxter GFM, Brar BK, Latchman DS, Yellon DM (1998) Infarct-limiting action of transforming growth factor beta-1 in isolated rat heart is abolished. Circulation 100:1–9
Baines CP, Wang L, Cohen MV et al (1999) Myocardial protection by insulin is dependent on phosphatidylinositol 3- kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol 94:188–198
Buerke M, Murohara T, Skurk C et al (1995) Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A 92:8031–8035
Cuevas P, Carceller F, Martinez-Coso V et al (1999) Cardioprotection from ischemia by fibroblast growth factor: Role of inducible nitric oxide synthase. Eur J Med Res 4:517–524
Stephanou A, Brar B, Heads R et al (1998) Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol 30:849–855
Morita K, Ihnken K, Buckberg GD et al (1995) Studies of hypoxemic/reoxygenation injury without aortic clamping. VIII. Counteraction of oxidant damage by exogenous glutamate and aspartate. J Thorac Cardiovasc Surg 110:1228–1234
Drinkwater DC Jr, Cushen CK, Laks H et al (1992) The use of combined antegrade-retrograde infusion of blood cardioplegic solution in pediatric patients undergoing heart operations. J Thorac Cardiovasc Surg 104:1349–1355
Us MH, Ozkan S, Oğuş T et al (2001) Efficacy of topically applied glutamate-aspartate and pentoxifylline solutions in decreasing myocardial damage during open-heart surgery in rats. J Int Med Res 29:497–502
Nakanishi K, Zhao ZQ, Vinten-Johansen J et al (1995) Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg 109:1146–1154
Bolling SF, Benedict MB, Tramontini NL et al (1998) Hibernation triggers and myocardial protection. Circulation 98:II220–II223 (discussion II223–II224)
Bolling SF, Tramontini NL, Kilgore KS, Su TP, Oeltgen PR, Harlow HH (1997) Use of “natural” hibernation induction triggers for myocardial protection. Ann Thorac Surg 64:623–627
Hong J, Sigg DC, Coles JA Jr et al (2005) Hibernation induction trigger reduces hypoxic damage of swine skeletal muscle. Muscle Nerve 32:200–207
Grabek KR, Karimpour-Fard A, Epperson LE et al (2011) Multistate proteomics analysis reveals novel strategies used by a hibernator to precondition the heart and conserve ATP for winter heterothermy. Physiol Genomics 43:1263–1275
Iles TL, Howard B, Howard SA et al (2015) Testing the efficacy of pharmacological agents in a pericardial target delivery model in the swine. JoVE (in press)
Skrzypiec-Spring M, Grotthus B, Szelag A, Schulz R (2007) Appraisal of state-of-the-art: isolated heart perfusion according to Langendorff–still viable in the new millennium. J Pharmacol Toxicol Methods 55:113–126
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Howard, B.T., Iles, T.L., Coles, J.A., Sigg, D.C., Iaizzo, P.A. (2015). Reversible and Irreversible Damage of the Myocardium: Ischemia/Reperfusion Injury and Cardioprotection. In: Iaizzo, P. (eds) Handbook of Cardiac Anatomy, Physiology, and Devices. Springer, Cham. https://doi.org/10.1007/978-3-319-19464-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-19464-6_16
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19463-9
Online ISBN: 978-3-319-19464-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)